Report Detail

Medical Devices & Consumables Global Medical Nuclide Decontamination Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4519201
  • |
  • 06 March, 2023
  • |
  • Global
  • |
  • 108 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Medical Nuclide Decontamination Agents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The medical nuclide decontamination solution has the functions of decontamination of nuclides (I-131, I-125, F-18, Tc-99m, U-235, U-238, P-32) and heavy metals and body surface disinfection. It is suitable for cleaning and disinfection of skin surface and object surface, and decontamination of radionuclides. This product is a special product for occupational defense institutes and nuclear medicine departments, and is used for daily use by medical staff or decontamination of patients for nuclear medicine diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Medical Nuclide Decontamination Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medical Nuclide Decontamination Agents market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Medical Nuclide Decontamination Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Medical Nuclide Decontamination Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Medical Nuclide Decontamination Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Nuclide Decontamination Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Nuclide Decontamination Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FJ, Jinsijia Security Technology, CBRN, UnitedOxydis and EPF, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Medical Nuclide Decontamination Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powdery
Liquid
Market segment by Application
Vocational Defense Institute
Nuclear Medicine
Military
Household
Others
Major players covered
FJ
Jinsijia Security Technology
CBRN
UnitedOxydis
EPF
Kusui
Cysterel
Trevachem
DuoRin
Kinhua
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Nuclide Decontamination Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Nuclide Decontamination Agents, with price, sales, revenue and global market share of Medical Nuclide Decontamination Agents from 2018 to 2023.
Chapter 3, the Medical Nuclide Decontamination Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Nuclide Decontamination Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Nuclide Decontamination Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Nuclide Decontamination Agents.
Chapter 14 and 15, to describe Medical Nuclide Decontamination Agents sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Medical Nuclide Decontamination Agents
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Nuclide Decontamination Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Powdery
    • 1.3.3 Liquid
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Nuclide Decontamination Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Vocational Defense Institute
    • 1.4.3 Nuclear Medicine
    • 1.4.4 Military
    • 1.4.5 Household
    • 1.4.6 Others
  • 1.5 Global Medical Nuclide Decontamination Agents Market Size & Forecast
    • 1.5.1 Global Medical Nuclide Decontamination Agents Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Medical Nuclide Decontamination Agents Sales Quantity (2018-2029)
    • 1.5.3 Global Medical Nuclide Decontamination Agents Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 FJ
    • 2.1.1 FJ Details
    • 2.1.2 FJ Major Business
    • 2.1.3 FJ Medical Nuclide Decontamination Agents Product and Services
    • 2.1.4 FJ Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 FJ Recent Developments/Updates
  • 2.2 Jinsijia Security Technology
    • 2.2.1 Jinsijia Security Technology Details
    • 2.2.2 Jinsijia Security Technology Major Business
    • 2.2.3 Jinsijia Security Technology Medical Nuclide Decontamination Agents Product and Services
    • 2.2.4 Jinsijia Security Technology Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Jinsijia Security Technology Recent Developments/Updates
  • 2.3 CBRN
    • 2.3.1 CBRN Details
    • 2.3.2 CBRN Major Business
    • 2.3.3 CBRN Medical Nuclide Decontamination Agents Product and Services
    • 2.3.4 CBRN Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 CBRN Recent Developments/Updates
  • 2.4 UnitedOxydis
    • 2.4.1 UnitedOxydis Details
    • 2.4.2 UnitedOxydis Major Business
    • 2.4.3 UnitedOxydis Medical Nuclide Decontamination Agents Product and Services
    • 2.4.4 UnitedOxydis Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 UnitedOxydis Recent Developments/Updates
  • 2.5 EPF
    • 2.5.1 EPF Details
    • 2.5.2 EPF Major Business
    • 2.5.3 EPF Medical Nuclide Decontamination Agents Product and Services
    • 2.5.4 EPF Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 EPF Recent Developments/Updates
  • 2.6 Kusui
    • 2.6.1 Kusui Details
    • 2.6.2 Kusui Major Business
    • 2.6.3 Kusui Medical Nuclide Decontamination Agents Product and Services
    • 2.6.4 Kusui Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Kusui Recent Developments/Updates
  • 2.7 Cysterel
    • 2.7.1 Cysterel Details
    • 2.7.2 Cysterel Major Business
    • 2.7.3 Cysterel Medical Nuclide Decontamination Agents Product and Services
    • 2.7.4 Cysterel Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cysterel Recent Developments/Updates
  • 2.8 Trevachem
    • 2.8.1 Trevachem Details
    • 2.8.2 Trevachem Major Business
    • 2.8.3 Trevachem Medical Nuclide Decontamination Agents Product and Services
    • 2.8.4 Trevachem Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Trevachem Recent Developments/Updates
  • 2.9 DuoRin
    • 2.9.1 DuoRin Details
    • 2.9.2 DuoRin Major Business
    • 2.9.3 DuoRin Medical Nuclide Decontamination Agents Product and Services
    • 2.9.4 DuoRin Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 DuoRin Recent Developments/Updates
  • 2.10 Kinhua
    • 2.10.1 Kinhua Details
    • 2.10.2 Kinhua Major Business
    • 2.10.3 Kinhua Medical Nuclide Decontamination Agents Product and Services
    • 2.10.4 Kinhua Medical Nuclide Decontamination Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Kinhua Recent Developments/Updates

3 Competitive Environment: Medical Nuclide Decontamination Agents by Manufacturer

  • 3.1 Global Medical Nuclide Decontamination Agents Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Medical Nuclide Decontamination Agents Revenue by Manufacturer (2018-2023)
  • 3.3 Global Medical Nuclide Decontamination Agents Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Medical Nuclide Decontamination Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Medical Nuclide Decontamination Agents Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Medical Nuclide Decontamination Agents Manufacturer Market Share in 2022
  • 3.5 Medical Nuclide Decontamination Agents Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Nuclide Decontamination Agents Market: Region Footprint
    • 3.5.2 Medical Nuclide Decontamination Agents Market: Company Product Type Footprint
    • 3.5.3 Medical Nuclide Decontamination Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Nuclide Decontamination Agents Market Size by Region
    • 4.1.1 Global Medical Nuclide Decontamination Agents Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Medical Nuclide Decontamination Agents Consumption Value by Region (2018-2029)
    • 4.1.3 Global Medical Nuclide Decontamination Agents Average Price by Region (2018-2029)
  • 4.2 North America Medical Nuclide Decontamination Agents Consumption Value (2018-2029)
  • 4.3 Europe Medical Nuclide Decontamination Agents Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Medical Nuclide Decontamination Agents Consumption Value (2018-2029)
  • 4.5 South America Medical Nuclide Decontamination Agents Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Medical Nuclide Decontamination Agents Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Medical Nuclide Decontamination Agents Sales Quantity by Type (2018-2029)
  • 5.2 Global Medical Nuclide Decontamination Agents Consumption Value by Type (2018-2029)
  • 5.3 Global Medical Nuclide Decontamination Agents Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Medical Nuclide Decontamination Agents Sales Quantity by Application (2018-2029)
  • 6.2 Global Medical Nuclide Decontamination Agents Consumption Value by Application (2018-2029)
  • 6.3 Global Medical Nuclide Decontamination Agents Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Medical Nuclide Decontamination Agents Sales Quantity by Type (2018-2029)
  • 7.2 North America Medical Nuclide Decontamination Agents Sales Quantity by Application (2018-2029)
  • 7.3 North America Medical Nuclide Decontamination Agents Market Size by Country
    • 7.3.1 North America Medical Nuclide Decontamination Agents Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Medical Nuclide Decontamination Agents Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Medical Nuclide Decontamination Agents Sales Quantity by Type (2018-2029)
  • 8.2 Europe Medical Nuclide Decontamination Agents Sales Quantity by Application (2018-2029)
  • 8.3 Europe Medical Nuclide Decontamination Agents Market Size by Country
    • 8.3.1 Europe Medical Nuclide Decontamination Agents Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Medical Nuclide Decontamination Agents Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Nuclide Decontamination Agents Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Medical Nuclide Decontamination Agents Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Medical Nuclide Decontamination Agents Market Size by Region
    • 9.3.1 Asia-Pacific Medical Nuclide Decontamination Agents Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Medical Nuclide Decontamination Agents Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Medical Nuclide Decontamination Agents Sales Quantity by Type (2018-2029)
  • 10.2 South America Medical Nuclide Decontamination Agents Sales Quantity by Application (2018-2029)
  • 10.3 South America Medical Nuclide Decontamination Agents Market Size by Country
    • 10.3.1 South America Medical Nuclide Decontamination Agents Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Medical Nuclide Decontamination Agents Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Nuclide Decontamination Agents Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Medical Nuclide Decontamination Agents Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Medical Nuclide Decontamination Agents Market Size by Country
    • 11.3.1 Middle East & Africa Medical Nuclide Decontamination Agents Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Medical Nuclide Decontamination Agents Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Medical Nuclide Decontamination Agents Market Drivers
  • 12.2 Medical Nuclide Decontamination Agents Market Restraints
  • 12.3 Medical Nuclide Decontamination Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Nuclide Decontamination Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Nuclide Decontamination Agents
  • 13.3 Medical Nuclide Decontamination Agents Production Process
  • 13.4 Medical Nuclide Decontamination Agents Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Nuclide Decontamination Agents Typical Distributors
  • 14.3 Medical Nuclide Decontamination Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Nuclide Decontamination Agents. Industry analysis & Market Report on Medical Nuclide Decontamination Agents is a syndicated market report, published as Global Medical Nuclide Decontamination Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Medical Nuclide Decontamination Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,724.84
    4,087.26
    5,449.68
    3,205.08
    4,807.62
    6,410.16
    545,907.60
    818,861.40
    1,091,815.20
    289,362.00
    434,043.00
    578,724.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report